These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21226277)

  • 1. [Chronic respiratory diseases and atherosclerosis].
    Teramoto S; Akashi S
    Nihon Rinsho; 2011 Jan; 69(1):158-62. PubMed ID: 21226277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
    Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
    J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic kidney disease and atherosclerosis].
    Koike M; Nitta K
    Nihon Rinsho; 2011 Jan; 69(1):144-50. PubMed ID: 21226275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients: the baseline findings of the MIAMI study.
    Porta B; Baldassarre D; Camera M; Amato M; Arquati M; Brusoni B; Fiorentini C; Montorsi P; Romano S; Tremoli E; Cortellaro M;
    Nutr Metab Cardiovasc Dis; 2008 May; 18(4):320-8. PubMed ID: 17889518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease in chronic obstructive pulmonary disease.
    Hunninghake DB
    Proc Am Thorac Soc; 2005; 2(1):44-9. PubMed ID: 16113468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus.
    Sabry AA; Elbasyouni SR; Kalil AM; Abdel-Rahim M; Mohsen T; Sleem A
    Nephrology (Carlton); 2006 Aug; 11(4):329-35. PubMed ID: 16889573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COPD: a disease with systemic inflammation].
    Rochat T
    Rev Mal Respir; 2012 Apr; 29(4):537-44. PubMed ID: 22542411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating systemic effects of COPD.
    Cazzola M; Matera MG; Rogliani P; Page C
    Trends Pharmacol Sci; 2007 Oct; 28(10):544-50. PubMed ID: 17897727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise-induced systemic effects in muscle-wasted patients with COPD.
    Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
    Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease].
    Malo O; Sauleda J; Busquets X; Miralles C; Agustí AG; Noguera A
    Arch Bronconeumol; 2002 Apr; 38(4):172-6. PubMed ID: 11953269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin.
    Lee TM; Lin MS; Chang NC
    Am J Cardiol; 2008 Feb; 101(4):530-5. PubMed ID: 18312772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic inflammation and mortality in chronic obstructive pulmonary disease.
    Sin DD; Man SF
    Can J Physiol Pharmacol; 2007 Jan; 85(1):141-7. PubMed ID: 17487253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence.
    Young RP; Hopkins R; Eaton TE
    Postgrad Med J; 2009 Aug; 85(1006):414-21. PubMed ID: 19633007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statins in COPD--theoretical reflections].
    Hannink JD; Heijdra YF
    Ned Tijdschr Geneeskd; 2010; 154():A2196. PubMed ID: 20977805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
    Galle J
    Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease.
    Fichtlscherer S; Breuer S; Heeschen C; Dimmeler S; Zeiher AM
    J Am Coll Cardiol; 2004 Jul; 44(1):44-9. PubMed ID: 15234404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
    Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
    J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes.
    O'Malley T; Ludlam CA; Riemermsa RA; Fox KA
    Eur Heart J; 2001 Jul; 22(14):1226-34. PubMed ID: 11440495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.